Table 1.
Clinical manifestations of 13 affected individuals in the FCL family
| ID | Sex | Age | Age of onset (year) | Skin lesions | System involvemenets | Mutation status |
|---|---|---|---|---|---|---|
| I-2 | F | Deceased (Unknow reason) | NA | + | NA | NA |
| II-2 | M | Deceased (Vital myocarditis) | NA | + | NA | NA |
| II-3 | F | 54 | Early childhood | + | N | NA |
| II-4 | F | Deceased (Suicide) | NA | + | NA | NA |
| II-5 | M | 47 | Early childhood | + | N | + |
| III-3 | F | 27 | Early childhood | + | Arthritis | + |
| III-4 | F | 27 | Early childhood | + | N | NA |
| III-5 | F | 25 | Early childhood | + | N | NA |
| III-6 | F | 24 | Early childhood | + | Arthritis | + |
| III-7 | F | 15 | Early childhood | + | N | + |
| IV-1 | M | 3.8 | 0.5 | + | Arthritis | + |
| IV-2 | F | 1.6 | 0.6 | + | Arthritis | + |
| IV-4 | M | 3.9 | 0.6 | + | N | NA |
(+) positive; N no, NA not available